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A bifidobacteria mix (nine strains) was evaluated for its effect on the
growth and survival of Escherichia coli O157:H7 (ATCC 43890) in 11% NFDM and
MRS broth under the optimum growth conditions for E. coli O157:H7 growth (37°C,
aerobic). Preliminary experiments were conducted to obtain the growth curves of the
9 strains of bifidobacteria and E. coli O157:H7 and confirm the inhibitory effect of
acidity on E. coli O157:H7 (pH of media adjusted to 3.8). Acid-adapted E. coli
O157:H7 showed no difference in resistance toward bifidobacteria (P>0.05) when
compared to the non-acid adapted one. Escherichia coli O157:H7 did not survive in
the supernatant of the bifodbacteria mix collected after incubation (37°C) with
aerobic shaking (8 h). However, the pathogen was able to grow after the pH of the
supernatant was adjusted to 6.50 (pH of fresh MRS broth). Results suggest that a high
content of bifidobacteria has a strong inhibitory effect on E. coli O157:H7, in part due

to the low pH. However, products from bifidobacteria may also exert inhibitory
effects.
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CHAPTER I
INTRODUCTION
Bifidobacteria, regarded as probiotics, have generated significant research
and commercial interest in recent years. “They are desirable, health-promoting
bacteria, with a saccharolytic and acidogenic physiology, and without involvement in
putrefying or toxigenic reactions or pathogenicity” (Crittenden, 2004). Fermented or
unfermented dairy foods, like milk, yoghurt, ice cream and cheese, are the most
popular food vehicles that are used to deliver these cultures (Boylston, et al., 2004).
They may also be found in powdered infant formulas, fermented soybean and
oat-based products, and in the fermentation of some animals’ (goat’s, sheep’s and
camel’s) milk. Although applications have developed very quickly, there are always
numerous challenges in maintaining a high level of viable and functional
bifidobacteria cultures throughout the shelf life of products, due to their strict
anaerobic and limited acid tolerance characteristics (Crittenden, 2004). Therefore, the
research on the response of bifidobacteria under unfavorable conditions requires more
attention. This may help to extend the application of bifidobacteria in the industry and
provide cost saving during processing.
1
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One of the most important health properties of bifidobacteria is their
antimicrobial activity toward pathogens. Bifidobacteria have been reported to inhibit
Clostridium

perfringens,

Salmonella

typhimurium,

Listeria

monocytogenes,

Campylobacter jejuni, Bacteroides vulgatus and Escherichia coli when there is a
large amount of viable cells (Leahy et al., 2005). Many authors suggest that the
inhibitory effect of bifidobacteria on pathogens in foods is derived from the
production of organic acids, hydrogen peroxide, bacteriocins and other antimicrobial
compounds when a large number of viable and functional colonies are present (Leahy
et al., 2005).
Escherichia coli O157:H7 is one of the most common food-borne
pathogens and is a public health concern all over the world. Infected people may
develop severe diarrhea, abdominal cramps, fever and/or blood in the stool. Its severe
consequences of infection (especially to young children and old people), low
infectious dose, and strong ability to survive under poor conditions make it imperative
to eliminate it in foods (CDC, 2006).
Researchers have confirmed the inhibitory effect of bifidobacteria on E. coli
O157:H7. However, methods used in experiments emphasize the need for anaerobic
conditions and a large number of viable bifidobacteria. Little information is available
about the influence of bifidobacteria on E. coli O157:H7 under aerobic conditions.
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Research in this area may deflate the limitation of bifidobacteria and lead to its
application in medicines and other food products besides dairy.
Therefore, the objectives of this project were: to study the inhibitory effect
of a bifidobacteria mix (nine strains) on E. coli O157:H7 under optimum growth
conditions for E. coli (37°C, aerobic), and to analyze the effect of pH of media and
supernatant created by bifidobacteria under aerobic conditions, on E. coli O157:H7.

CHAPTER Ⅱ
LITERATURE REVIEW
Bifidobacteria: History
Bifidobacteria was first discovered by Henry Tissier (1900) in 1899 at the
Pasteur Institute, Paris, France. It was isolated from the feces of breast-fed infants and
has an irregular Y shape. At the same time, a bacterium Moro (1900) discovered in
similar conditions was considered to belong to the genus Lactobcillus, because of its
rod-like shape and obligate fermentative characteristics. With the discovery of
fructose-6-phosphoketolase (F6PPK) (characteristic enzyme in bifidobacteria) and
specific DNA segment, the genus Bifidoabcium was found to be different from that of
Lactobacillus, Corynebacterium, and Propionibacterium (Sebald et al. and Werner et
al., 1965). Therefore, in the 8th editon of Bergey’s Manual of Determinative
Bacteriology, bifidobacterium was regarded as an individual genus and constituted 11
species (Rogosa, 1974). Presently, the genus has reached more than 30 species
(Appendix Table 1), isolated mainly from the gastrointestinal tract of various animals
and humans. (Biavati et al., 2000)

4
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Characteristics of Bifidobacteria

Morphology
Bifidobacteria are Gram-positive, non-sporeforming, non-motile, irregular
rods. Some of them are curved, some are clubbed and most are branched.
Bifidobacteria include cornynebacteria, mycobacteria and streptomycetes (Embley
and Stackerandt, 1994). In unnatural habitat, strains of bifidobacteria may have
different forms, like bifurcated Y and V forms, spatulate or club shapes, branching
and pleomorphism. Different composition and different levels of certain constituents
of the culture medium are also responsible for different shapes of bifidobacteria
strains (Mayer et al., 1950). The amount of N-acetylglucosamine, alanine, aspartic
acid, glutamic acid, serine and Ca2+ ions in the growth medium influence the cell
shape of bifidobacteria (Scardovi, 1984).

Ecology
All species of bifidobacteria are found in six different habitats: the human
intestine, oral cavity, food, the animal gastrointestinal tract (GIT), the insect intestine,
and sewage (Appendix Table 1). Bifidobacteria is a major part of the normal intestinal
microflora in humans for all their life and about 3% of the total fecal microflora of
adults (Sghir et al., 2000). They appear in the feces of human infants a few days after
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their birth and then continue to increase in number after that. Bifidobacteria enters
the body of infants through their mouth. Several factors, like methods of feeding,
constituents of milk and environment may influence the growth of bifidobacteria in
vivo. Breast-fed babies were found to have much more bifidobacteria in the infant gut
than formula-fed infants. This might be attributed to the bifidogenic factors present in
human milk. (Harmsen et al., 2000). The number of bifidobacteria in the colon of
adults is 108 - 1011 CFU, but this number decreases with age. Bifidobacterium
adolescentis and B. longum are major bifidobcteria species in the adult intestine and B.
infantis and B. breve are predominant species in the intestinal tract of human infants
(Mutai et al., 1987; Gavini et al., 2001). The number of viable bifidobacteria is
regarded as a marker of the stability of the human intestinal microflora (Mutt and
Tanaka, 1987).

Physiology
Bifidobacteria species isolated from humans grow at 36ºC-38ºC, whereas
bifidobacteria from animals have a higher optimum growth temperature, 41-43ºC.
Bifidobacteria cannot grow below 20 ºC. However, Simpson et al. (2004) discovered
that B. thermacidophilum was able to grow at a maximal temperature of 49.5 ºC and
B. psychraerophilum was shown to grow at as low as 4 ºC.
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Bifidobacteria are acid-tolerant microorganisms. They also cannot survive
in an environment at pH higher than 8.5 (Biavati et al., 2000) The suitable pH is
between 6.5 and 7.0. No growth is recorded at pH lower than 4.5; except for strains of
B. lactis and B. animalis, which can survive at pH 3.5, and B. thermoacidophilum,
which has a delayed growth at pH 4.0 (Matsumoto et al., 2004).
Bifidobacteria are described as strictly anaerobic microorganisms (Scardovi
1984). However, the sensitivity toward oxygen can vary between species and between
different strains within a species (Shimamura et al., 1992; Ahn et al., 2001).
Hydrogen peroxide and superoxide are the products of fructose-6-phosphoketolase
(F6PPK) under aerobic conditions. They are able to inactivate the enzyme and
therefore cause the death of bifidobacteria.
There are three kinds of responses when conditions change from anaerobic
to aerobic. First, the reduction of NAD-oxidase, NAD-peroxidase and superoxide
dismutase helps B. breve, B. infantis and B. longum strains survive from oxygen
toxicity. The weak catalase activity and the effect of NADH oxidase can remove or
avoid the synthesis of hydrogen peroxide, which increases the tolerance of some
strains to oxygen (Ventura et al., 2004). Secondly, bifidobacteria strains are able to
grow very slowly or just survive with the accumulation of hydrogen peroxide. Thirdly,
some bifidobacteria strains require a low redox potential (accumulation of hydrogen
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peroxide) for growth. The metabolism of oxygen dissimilation in bifidobacteria is
shown in Figure 2.1 (Ballongue, 1993).

Carbohydrates
O2

F6PPK pathway
Glucose

Organic acid
(like lactic acid
and acitic acid)

NADH
NADH oxidase
O2

NADH peroxidase
H2O2

O2

H2O

Superoxide
dismutase
H2O2

Figure 2.1

Oxygen dissimilation in Bifidobacterium (Ballongue, 1993)
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2Glucose
2ATP

1

2ADP

Fructose-6-P

Fructose-6-P

2

Pi

Erythrose-4-P

3

Glyceraldehyde-3-P

Sedoheptulose-3-P

5

Acetyl-P
2Acetyl-P

8

3Acetate

2Pi

4
Ribose-5-P

3ATP

3ADP

1+1 Xylulose-5-P

7

2Pi

6

Ribulose-5-P

2Glyceraldehyde-3-P
2NAD
9

2NADH2

………

2NADH2
2NAD

Pyruvate

10

4ADP
4ATP

2L(+) lactate
1 = hexokinase and glucose-6- phosphate isomerase; 2 = fructose-6-phosphoketolase;
3 = transaldolase; 4 = transketolase; 5 = ribose-5-phosphate isomerase; 6 =
ribulose-5-phosphate epimerase; 7 = xylulose-5-phosphate phosphocetolase; 8 =
acetate kinase; 9 = homofermentative pathway enzymes; 10 = L(+) lactate
dehydrogenase

Figure 2.2

Metabolic pathway of Bifidobacterium sp. (Tamine et al., 1995)
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Metabolism
Bifidobacteria create organic acids (Figure 2.2). Hexoses are degraded by
F6PPK and this mechanism led to the discovery of this characteristic enzyme
(Scardovi, 1986). Acetate and half of the lactate are created by the fermentation of
glucose; the other half of the lactate is transferred from pyruvic acid through L(+)
lactate dehydrogenase. (Tamine et al., 1995)
Bifidobacteria strains isolated from human can also synthesize vitamins,
thiamine (B1), riboflavin (B2), pyridoxine (B6), folic acid (B9), cyanocobalamine (B12)
and nicotinic acid (PP) (Deguchi et al., 1985).
As was mentioned, F6PPK is the key enzyme for bifidobacteria for the
fermentation of sugars. There are three types of this enzyme, from three different
ecological sources: mammalian, bee or human. (Scardovi et al., 1971) The F6PPK is
also a specific enzyme to the genus which is absent in other anaerobic bacteria
similarto bifidobacteria (Scardovi and Trovatelli, 1965). Therefore, the activity of
F6PPK is often used to detect and identify bifidobacteria (formation of reddish-violet
color in cellular extracts containing F6PPK). “The detection of F6PPK in cellular
extracts, is considered to be the most reliable indication that Gram-positive
rod-shaped bacteria belong to the genus Bifidobacterium” (Gavini et al., 1996). The
method has been modified several times. Orban and Patterson (2000) used the method
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of incubation in hexadecyltrimethylaminonium bromide (CTAB) for five minutes
instead of sonication to release cellular extract and to reduce cost and time. Other
tests, like pulsed field gel electrophoresis (PFGE) of whole chromosomal DNA,
random amplified polymorphic DNA (RAPD) assays, and genus–specific PCR
primers, can be used to identify certain strains of bifidobacteria. However, most of
these tests are expensive and time-consuming.

Health Benefits of Bifidobacteria
Bifidobacterium adolescentis, B. animalis, B. bifidum, B. breve, B. infantis,
B. lactis and B. longum are probiotics (Holzapfel et al., 1998). The health of humans
and animals are improved when these viable cells are added to diets (Salminen et al.,
1998). They help to synthesize the vitamins in yogurt and improve the absorption of
minerals and protein (Ding et al., 2005).
As for therapeutic benefits, bifidobacteria can be used to treat
gastrointestinal tract diseases and lactose intolerance. In Egypt, B. bifidum combined
with other probiotics reduced the incidence of travel diarrhea from 71 to 43% (Black
et al., 1989). These bacteria can also improve host immune system, modulate
abnormal inflammatory responses in allergies, bowel disease and also improve the
function of immune system against pathogens and cancer cells (Crittenden, 2004).
Bifidobacterium longum and B. breve were reported to prevent carcinogens from
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affecting DNA. Bifidobacterium longum reduces the creation of tumors, and creates
anticancer linoleic acid (Rosberg-Cody et al., 2004). As for other diseases,
bifidobacteria was also suggested to reduce serum cholesterol and alleviate
constipation (Leahy et al., 2005). Plummer et al. (2004) suggested that B. bifidum
could also help to neutralize toxin and reduce the possibility of diarrhea caused by
antibiotics.

Antagonistic Effect of Bifidobacteria on Escherichia coli O157:H7 - Mechanism
Antimicrobial activity of bifidobacteria in vivo is mainly based on
adhesiveness properties, bacterial interference, production of antimicrobial substances
and stimulation of mucosal immunity. Until now, research has emphasized that high
levels of viable cells of bifidobacteria are necesary for antimicrobial activity.
Therefore, all experiments has been conducted under anaerobic conditions, and not
much information is available pertaining to the behavior of bifidobacteria under
aerobic conditions.
Caco-2 and HT29-MTX cells are the constituents of intestinal epithelium.
Bifidobacterium adolescentis, B. angulatum, B. bifidum, B. breve, B. catenulatum, B.
infantis, B. longum and B. pseudocatenulatum can adhere to Caco-2 cells, and the
mucus secreted by HT29-MTX cells, the places that are also adhered by pathogens.
The competition for adherence between bifidobacteria and pathogens helps to reduce
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the frequency of infection. Bifidobacterium lactis DR 10 interferes with the binding
of E. coli O157:H7 to the intestinal cells, and therefore reduces the invasiveness of
the pathogen (Servin, 2004). Chiang et al. (2000) also suggested that B. lactis induced
intestinal mucin gene expression to modulate the barrier effect of the gut, that
inhibiting E. coli adherence.
The main antimicrobial products of bifidobacteria are organic acids (lactic
and acetic acid), hydrogen peroxide, and bacteriocins. Shelef (1994) cited that the
inhibitory effect of organic acids were due to chelation of iron and inhibition of
lactate dehydrogenase. Weak acids have stronger antimicrobial activity at low pH,
making acetic acid more effective than other acids. Antimicrobial ability of organic
acids depends on their undissociated form. Therefore, low pH is necessary. Lactic
acid can reduce pH and permeate membranes of pathogens. Asahara et al. (2004)
concluded that a high concentration of acetic acid and a low pH that can be created by
bifidobacteria were able to inhibit Shiga-like toxin production of E. coli O157:H7.
Hydrogen peroxide can oxidize cells of bacteria, sulfhydryl groups of cell proteins,
and membrane lipids. Bacteriocins have antimicrobial properties and are thought to
be natural preservatives. However, so far “there is not enough evidence to improve
the effect of bacteriocins, collected from gram-positive bacteria, on gram-negative
bacteria without the addition of any membrane-active compounds” (Ouwehand and
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Vesterlund, 2004). Therefore, there is no evidence to make sure that bacteriocins can
be utilized in vitro. More research needs to be accomplished. Besides the direct effect
of bifidobacteria on the survival of pathogens, Li et al. (2005) suggested that
bifidobacteria DNA can improve the activity of murine macrophages J774A.1
(immune system) in vitro.

Escherichia coli O157:H7
Escherichia coli are one of the main bacteria that live in the intestines of
humans and animals. They are Gram-negative, facultative, anaerobic rods. Most of
them are harmless. However, there are six pathogenic groups: enteropathogenic
(EPEC), enterotoxigenic (ETEC), enterohemorrhagic (EHEC), enteroinvasive (EIEC),
enteroaggregative (EAEC), and diffusely adherent (DAEC). Escherichia coli
O157:H7 belongs to the EHEC group and because of their ability to produce
Shiga-like toxins (or verotoxins), they are also considered to be Shiga-like toxin
producing E. coli (STEC) (or verotoxin E. coli, VTEC). (Levine, 1987)
The expression of somatic (O) antigen 157 and flagellar (H) antigen 7
defines E. coli O157:H7 and the bacteria were first isolated in the U.S. in 1975. In
1982, E. coli O157:H7 caused bloody diarrhea in two separate cases that occured in
Oregon and Michigan. These outbreaks were associated with contaminated
hamburgers (Konowalchuk et al., 1977). The next year, a report on hemorrhagic
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colitis (HC) confirmed E. coli O157:H7 as a pathogen (Riley et al., 1983). In 1985,
Karmali et al. reported that STEC caused hemolytic uremic syndrome (HUS). Due to
its wide range of distrubution vehicles and infection with limited colony number, E.
coli O157:H7 has been regarded as one of the leading bacterial cause of human
gastrointestinal disease. Large outbreaks have occurred in a number of countries and
great attention has been received thereafter.
Escherichia coli O157:H7 is indole positive and oxidase negative. It can
produce lactose-fermenting, nonmucoid colonies like other E. coli, whereas it fails to
ferment sorbitol causing it to appear colorless, while other coliform bacteria produce
pink colonies on MacConkey sorbitol agar. (Padhye and Doyle, 1992)
Although, MacConkey sorbitol agar is a good selective medium for E. coli
O157:H7, it is useless on the recovery of injured or stressed colonies. Silk and
Donnelly (1997) reported that Tryptic Soy Agar (TSA) or TSA overlayed with violet
red bile agar can be used to recover injured and stressed E. coli O157:H7 colonies.

Escherichia coli O157:H7 Pathogenicity and Outbreaks
Escherichia coli O157:H7 is a normal inoffensive bacterium that becomes
pathogenic after being combined with foreign DNA through transfer (such as
conjugation, bacteriophagic transfers or natural transformations (Boerlin, 1999;
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Boerlin et al., 1999)). The main pathogenicity mechanisms of E. coli O157:H7 are
described in Figure 2.3.
The first pathogenicity mechanism of E. coli O157:H7 is Locus for
enterocyte effacement (LEE). This locus encodes a type III secretion system (TTSS),
the translocated intimin receptor (Tir), intimin and other effector proteins (E.
coli-secreted proteins (Esp)). These bacterial genes are able to attach pathogens to
intestinal cells and destroy microvilli, known as the Attaching and Effacing (A/E)
lesion. The TTSS is responsible for transporting virulent factors (Esp) directly to the
cell cytoplasm (LeBlanc, 2003). Tir is regarded as an intimin receptor and does not
phosphorylate in E. coli O157:H7 which is different with Enteropathogenic E. coli
(EPEC) (Calderwood, 1996). Recent studies discovered that nucleolin and betal
integrin were also present as receptors for intimin (function as a membrane adhesion
(Frankel et al., 1996)) on the luminal surface of intestinal epithelia during the
infection of E. coli O157:H7 (Sinclair et al., 2006).
The second pathogenicity mechanism of E. coli O157:H7 (Figure 2.3) is
Shiga-like toxins (vero cytotoxins). Shiga toxin-producing E. coli may produce Stx1
or Stx2 or both of these two toxins (Chart, 2000). Stx2 was reported to be more toxic
to human renal endothelial cells than Stx1 (Scotland et al., 1987). Toxins have an AB
structure, five B polypeptides linked with one A polypeptide (O’Brien and Holmes,

17
1987). After entering the cell through endocytosis, the B-pentamer plays an important
role for toxins to bind to globotriaosylceramide (Gb3), which is in the cortex of the
human kidney. (Sandvig and van Deurs, 1996; Schmidt et al., 1996) Meanwhile, the
A subunit is an N-glycosidase that inhibits the synthesis of proteins by cleaving a
single adenine residue from the 28S (Sandvig et al., 1992). In the intestine, the
destruction of epithelial cells alters the secretion and absorption of electrolytes, which
might cause diarrhea (Kandel et al., 1989). Acetic acid and low pH was suggested for
the inhibition of the Stx production of the pathogen (Asahara et al., 2004)
The third pathogenicity mechanism of E. coli O157:H7 (Figure 2.3)
plasmid. Its main virulent genes are KatP, EspP, etpC-O, hlyA-D and toxB (LeBlanc,
2003). Nataro and Kaper (1998) proposed that KatP, as a bifunctional
catalase-peroxidase, could protect bacteria from oxidative stress derived from host
cells. Since EspP, as plasmidic serine proteases, can dissolve Vero cells and destroy
pepsin A and human coagulation factor V, it helps bacteria to access to host cells
(Brunder et al., 1997). A type II secretion system exists from etpC to etpO (LeBlanc,
2003). The four genes from hlyA to hlyD are responsible for the creation of
EHEC-hemolysin (Brunder et al., 1997).

18
Type III secretion system

Tir

Intimin

escRSTU

tir

eae

escCJ

escVN

Esp proteins

espADB

CHROMOSOME
Shiga-like toxins
(verotoxins)

stxA
espP

stxB

etpC-O

katP

toxB

Figure 2.3

HlyA-D

pO157

Schematic representation of the main pathogenicity mechanisms of
Escherichia coli O157:H7 (LeBlanc, 2003)

The fourth pathogenicity mechanism of E. coli O157:H7 (Figure 2.3) is
through Lipopolysaccharides (LPS). LPS is known as somatic (O) antigen and
regarded as a marker for the detection of E. coli O157:H7 (De Boer and Heuvelink,
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2000). Lipid A and O polysaccharides constitute LPS. The O polysaccharide was
suggested to have an effect on the adherence of E. coli O157:H7 to the host cells.
(Bilge et al., 1996) Lipopolysaccharide and Stx2 have been found to induce the
release of chemokines and other factors in the microvascular endothelial cells. These
factors combine with low level of primary agonists to activate the renal thrombosis
associated with hemolytic uremic syndrome (HUS). (Guessous et al., 2005)
The ingestion of contaminated food (ground beef, sprouts, lettuce, salami,
unpasteurized milk and juice) or water, or by person-to-person transmission, causes
the E. coli O157:H7 infection. Escherichia coli O157:H7 mainly causes hemorrhagic
colitis (HC), HUS, and/or thrombotic thrombocytopenic purpura (TTP). (Park et al.,
2001) The symptoms of these diseases are severe bloody diarrhea and abdominal
cramps. Sometimes, a little fever might be present. Usually, the infection will end
without specific treatment in 5-10 days and antibiotics and antimotility medications
will induce the complications. Children under 5 years of age and elders will usually
have HUS which is complicated from the E. coli O157:H7 infection, causing
destruction of red blood cells and kidney failure (CDC, 2006). The TTP often occurs
in adults. It lacks prodromal and therefore it is much more dangerous and less
predictable in patients than HUS. Patients often develop a blood clot in the brain and
die. (Proesmans, 1996)
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Outbreaks of E. coli O157:H7 occur all over the world. With the
improvement in surveillance for E. coli O157:H7 in the United States (U.S.), the
number of infectious cases caused by contaminated hamburgers from restaurants has
decreased (Park et al., 2001). During 2004-2005, petting zoos was reported as
vehicles for E. coli O157:H7 infections. Three outbreaks occurred in North Carolina,
Florida, and Arizona. Children, who visited these zoos were infected with HUS (CDC,
2005). Unlike in the U.S., infections caused by E. coli O157:H7 in the United
Kingdom (U.K.) have increased in recent years. Infections often happen in the
summer and on children 0-4 years old (Douglas and Kurien, 1997). Ground beef
products are typical foods to cause the infection in the U.S. and U.K.

Among Asian

countries, Japan has the most reports on E. coli O157:H7 infections. In South
America, E. coli O157:H7 frequently causes diarrhea, HUS. In Canada, E. coli
O157:H7 is one of most prevalent pathogens that causes infection, and it has been
suggested that control of this pathogen at the farm level will reduce the risk of its
infection (Park et al., 2001). Escherichia coli O157:H7 has been more frequently
regarded as an enteric pathogen in developed countries than in developing countries.
This may be due to a lack of surveillance systems in developing countries (Phillip et
al., 2001).
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Factors Affecting Survival and Growth of Escherichia coli O157:H7
E. coli O157:H7 infections occur through consuming a variety of foods,
such as raw or undercooked meat, contaminated apple cider and juice, fruit,
vegetables, and water. This suggests that E. coli O157:H7 may have strong tolerance
to rigorous environments. (Tarr et al., 1997; Raghubeer and Matches, 1990)

Temperature
Many E. coli O157:H7 strains grow poorly above 44°C. The minimum
growth temperature for E. coli O157:H7 is around 8-10°C (Buchanan and Bagi, 1994;
Rajkowski and Marmer, 1995). However, cell growth depends on the constitution of
media. They cannot grow well in Tryptic Soy Broth (TSB) at 44-45°C (Doyle and
Schoeni,, 1984). All strains can grow in brain heart infusion (BHI) broth at 45°C, but
six of them cannot grow in E. coli (EC) broth at the same temperature. (Palumbo et
al., 1995)
Nevertheless, E. coli O157:H7 can grow fairly well in foods. There is no
great change in colony number of E. coli O157:H7 in ground beef that is initially
stored at -80°C and then held at -20°C for up to 9 months (Doyle and Schoeni, 1984).
Escherichia coli O157:H7 grows very quickly in cantaloupe and watermelon cubes at
25°C (del Rosario and Beuchat, 1995). The greater survival of E. coli O157:H7 at
22°C than at -10 and 4°C in feces from corn- and barley-fed steers suggested that
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temperature may help to seasonally transmit and spread the pathogen in feedlot cattle
(Bach et al., 2005). Modified atmospheres have no effect on the growth of E. coli
O157:H7 at both 12 and 21°C, on shredded lettuce or sliced cucumbers (Abdul-Raouf
et al., 1993a).

Low pH
Escherichia coli O157:H7 survives in several acid foods (Buchanan and
Doyle, 1997). It can grow quite well at pH 5.5-7.5. The minimum pH for growth is
4.0-4.5, below which populations will decline very quickly (Buchanan and Bagi, 1994;
Buchanan and Klawitter, 1992). Acid tolerance depends on the growth phase of E.
coli O157:H7 (Gorden and Small, 1993). Stationary-phase cells are more resistant to
acid than log-phase cells and do not need exposure to low pH to induce acid
resistance. Log-phase cells need to be exposed to pH 5.5-6.0 to induce acid resistance
(Arnold and Kaspar, 1995). The type of acid and acid concentration influence the
effect of pH on E. coli O157:H7. Some organic acids (acetic, lactic and citric acid)
have an inhibitory effect on E. coli O157:H7. (Abdul-Raouf et al., 1993) Recently,
study on this area found that colonic acid (CA), created by E. coli O157:H7, increased
the tolerance of E. coli O157:H7 to the extreme pH of microbiological culture media
(Lee and Chen, 2004).
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The acid tolerant state of E. coli can last longer if incubated at refrigeration
temperature. Escherichia coli O157:H7 can survive in apple cider for only 2-3 days at
25°C, but 31 days at 8°C (Zhao et al., 1993). At high populations, E. coli O157:H7
can survive in mayonnaise (pH 3.6-3.9) for 5-7 weeks at 5°C, but only 1-3 weeks at
20°C (Zhao and Doyle, 1994). Escherichia coli O157:H7 (103-107 CFU/ml) survived
yogurt fermentation for 5 h at 42°C but 1 week at 4°C (Gorden and Small, 1993).
Acid tolerance also helps E. coli O157:H7 resist other environmental stresses. It has
been reported that the resistance of E. coli O157:H7 toward heating, radiation and
antimicrobials increases due to the induction of acid tolerance (Rowbury, 1995)
causing cells to more easily cause infections.

Water (Effect of NaCl)
Escherichia coli O157:H7 (initially 104 CFU/g) was reported to survive
fermentation, drying and storage for 2 months at 4°C in fermented sausage which
contained 69 ppm sodium chloride (Glass et al., 1992). Since E. coli O157:H7 is in a
viable but nonculturable (VBNC) state in water, it cannot be detected by traditional
plating methods (Masaki et al., 1992), thus difficult to detect in contaminated water. A
risk assessment process should be performed when the effect of the pathogen in
drinking water cannot be predicted by monitoring system (Schets et al., 2005).
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Escherichia coli O157:H7 cannot grow in TSB containing greater than
6.5% NaCl (Harrison, 1996). Harrison (1996) also indicated that E. coli O157:H7
could not be recovered from drying beef strips at 60°C for 10 h. Keene et al. (1997)
reported that E. coli O157:H7 was killed slowly in marinated meat when dried at
51.7°C; and was only detectable by enrichment after drying for 6-8 h at 62.8°C.
However, Hengge-Aronis et al. (1993) indicated that if E. coli O157:H7 was grown in
relatively high levels of NaCl, thermotolerance and H2O2 resistance increased,

and

that the pathogen can survive for many weeks in a dry state, especially at refrigerated
temperatures (Bagi and Buchanan, 1993).

Probiotics
Probiotics, such as lactic acid bacteria and especially bifidobacteria, are
often applied as starter cultures in fermented foods. These fermented food products
have been produced safely for many years without heat treatment. The growth of E.
coli O157:H7 is inhibited in those foods (Barrantes et al., 2004).
As for yogurt, although different cultures vary in their ability to inhibit the
growth of E. coli O157:H7 in fermented systems (Dineen et al., 1998), Barrantes et
al., (2004) confirmed that yogurt with additional probiotic cultures had inhibitory
effects on E. coli O157:H7, when E. coli O157:H7 was cultured in yogurt with no
additional probiotics. In addition, fermentation temperature and subsequent storage
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temperature are also quite important to the growth and survival of E. coli O157:H7 in
yogurt involving probiotics (Ogwaro et al., 2002).
Probiotics were able to inhibit the growth of E. coli O157:H7 in vivo and in
vitro. The creation of organic acids (lactates and acetates), hydrogen peroxide and
bacteriocins, the competition, and adhesion receptors in the body, aid human beings
ability in fighting against E. coli O157:H7 (Leahy et al., 2005). Use of Bdellovibrio
spp. reduce the E. coli O157:H7 counts on stainless steel surfaces after 7 h incubation
within the temperature range from 19 to 37°C and can be used to protect food from
contaminated processing equipment (Fratamico and Cooke, 1996).

CHAPTER III
MATERIALS AND METHODS
Bacterial Cultures: Bifidobacteria and Escherichia coli O157:H7
Bifidobacterium lactis/animalis Bb12; B. bifidum 15696; B. longum 15708;
B. bifidum 791; B. longum VMKB S2B; B. longum VMKB 211; B. bifidum VMKB
221; B. bifidum VMKB 213 and Bifidobacterium spp. VSB1 were obtained from
James L. Steele (University of Wisconsin, Madison, WI, USA), All of which were
isolated from human intestines except Bifidobacterium lactis/animalis Bb12, which
was isolated from milk (Appendix Table 1). Escherichia coli O157:H7 (ATCC 43890)
was obtained from Dr. Juan L. Silva (Mississippi State University, MS, USA).
All cultures of bifidobacteria and E. coli O157:H7 were maintained in 50%
glycerol and 11% nonfat dry milk (NFDM) stock and stored at -80°C. The 11%
NFDM was prepared by combining agglomerated instant nonfat dry milk (Land
O’Lakes, Inc., St. Paul, MN, USA) with double-distilled water to contain 11% total
solids. This mixture was then autoclaved at 121°C for 15 min. Bifidobacterial strains
were reactivated in de Man, Rogosa, Sharpe (MRS) broth (Becton Dickinson, Sparks,
MD, USA) (De Man et al., 1960) and incubated under anaerobic conditions using an
26
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anaerobe container system (BD GasPak TM EZ, Becton Dickinson, Sparks, MD, USA)
at 37°C. Escherichia coli O157:H7 was reactivated in Tryptic Soy Broth (TSB;
Becton Dickinson) and incubated aerobically at 37°C with shaking at 100 rpm (C24
Incubator shaker, New Brunswick Scientific, Edison, NJ, USA). All cultures were
subcultured at least two times prior to experimentation. (Gagnon et al., 2004)
Ten microliters of each of the nine strains of bifidobacteria were transferred
to fresh MRS broth and incubated at 37°C for 16 h under anaerobic conditions to
develop the growth curve. Their pH value (Corning Pinnacle 530 pH meter, Corning
Incorporated,

Corning,

NY,

USA)

and

turbidity

at

600

nm

(UV-1201

Spectrophotometer, Shimadzu Corporation, Columbia MD, USA) were measured.
Ten microliters of E. coli O157:H7 were transferred to fresh TSB and
incubated at 37°C for 24 h with aerobic shaking at 100 rpm (C24 Incubator shaker) to
obtain the growth curve. As for acid-adapted E. coli O157:H7, 10 μl of E. coli
O157:H7 were transferred to TSB supplemented with 10 g/l glucose (final pH
following incubation 4.8±0.007) and incubated at 37°C for 24 h with aerobic shaking
at 100 rpm (C24 Incubator shaker) to obtain the growth curve. Media were acidified
with 1 N hydrochloric acid (Dave and Shan, 1996). Their pH value and turbidity at
600 nm was measured. The growing colony number of acid-adapted and unadapted E.
coli O157:H7 was also measured every hour during incubation. Serial dilutions in
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sterile 0.1% peptone (Fisher, Pittsburgh, PA, USA) (0.1 g/100ml double-distilled H2O)
were prepared from the samples, and appropriate dilutions were spread plated in
duplicate on Tryptic Soy Agar (TSA; Becton Dickinson, Sparks, MD, USA). Plates
were incubated at 37°C for 24 h (Leenanon and Drake, 2001).
Bifidobacterial colonies were confirmed by Gram-staining and by the
detection of intracellular fructose-6-phosphoketolase (F6PPK). Detection of F6PPK
was accomplished by a modification of the microanalysis procedure described by
Orban et al. (2000) and Vlková et al. (2002). All reagents for this analysis were
obtained from Fisher (Pittsburghm, PA, USA) unless stated otherwise. Each of the
nine strains of bifidobacteria was cultivated anaerobically in 10 ml MRS broth at
37°C for 14 h in an anaerobic box (full-growth), respectively. The cells of each strain
were washed twice with phosphate buffer and centrifuged (Sorvall® Biofuge Fresco,
Newtown, CT, USA) at 16,000×g (4°C, 3 min). The phosphate buffer was prepared as
a mixture (1:1(v/v)) of KH2PO4 (0.05M) and cysteine-HCl (500 mg/liter) and the
buffer was adjusted to pH 6.5 with fresh NaOH. The newly washed cells were
resuspended in 1.0 ml phosphate buffer. These cells were incubated with 0.4 ml of
hexadecyltrimethylaminonium bromide (CTAB) (450mg CTAB in 1 ml of
double-distilled H2O) for 5 min for cell disruption. Then, a reaction mixture
containing 0.25 ml of a solution containing sodium fluoride (Sigma, St. Louis, MO,
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USA) and sodium iodoacetate (6 mg NaF and 10 mg Na iodoacetate in 1ml
double-distilled H2O), 0.25 ml of sodium fructose-6-phosphate (Sigma) (80 mg/ml in
water) was added into the mixture of each strain and vortexed (Fisher Scientific Mini
Vortexer). After 30 min of incubation at 37°C, the reaction was terminated by the
addition of 1.5 ml hydroxylamine HCl (13.9 g/100ml of double-distilled water,
freshly neutralized with NaOH to pH 6.5) and vortexed. The mixture of each strain
was kept for 10 min at room temperature (around 20°C) and then 1 ml of TCA
(trichloroactic acid; 15% (w/v) in water), 1.0 ml of 4N HCl and 1.0 ml of
color-developing ferric chloride (FeCl·6H2O (Sigma), 5% w/v in 0.1N HCl) were
added. Tubes were vortexed and reddish-violet color formation was determined using
a Spectronic® GENESTSTM Spectrophotometer (Spectronic Instruments, Inc.,
Rochester, NY, USA). The supernatant of the reaction mixture of each strain was
collected by centrifugation at 16,000×g (Sorvall® Biofuge Fresco) (4°C for 3 min)
and measured at 435 nm, respectively. The blank was prepared by mixing all reagents
except bifidobacteria cells (negative when the reaction mix develops a light yellow
color).

Effect of Low pH on the Growth of Escherichia coli O157:H7
Escherichia coli O157:H7 cells were prepared by culturing for 12 h at 37°C
in TSB with aerobic shaking at 100 rpm (C24 Incubator shaker). One milliliter of
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cells was washed twice by centrifugation at 1000×g (Sorvall® Biofuge Fresco) (4°C,
2 min) with 0.85% NaCl (0.85 g/100ml double-distilled water). Ten microliters of
cells were suspended in acid-adjusted 11% NFDM (pH 3.81 before growth) and MRS
broth (pH 3.94 before growth), and incubated at 37°C for 24 h with aerobic shaking at
100 rpm (C24 Incubator shaker). Media were acidified with 1 N hydrochloric acid
(Dave and Shan, 1996). For the control, 10 μl of cells were suspended and then
cultured in unadjusted 11% NFDM (pH 6.39 before growth) and MRS broth (pH 6.46
before growth) at 37°C for 24 h with aerobic shaking at 100 rpm (C24 Incubator
shaker). Samples were collected during the incubation period at 0, 4 (log phase), 8
(stationary phase) and 24 h. The colony forming units (CFU/ml) of E. coli O157:H7
were measured using a spread plate method on TSA (Silk and Donnelly, 1997).

Inhibitory Effect of Bifidobacteria on Escherichia coli O157:H7
The cultures of nine bifidobacteria strains were centrifuged (Sorvall®
RC-5B PLUS Superspeed Centrifuge, Sorvall® Centrifuges, Newtown, CT, USA)
together at 4,300×g (4°C, 15 min) after each was grown separately at 37°C for 14 h in
10 ml MRS broth under anaerobic conditions. One milliliter of E. coli O157:H7 was
centrifuged at 1,000×g (Sorvall® Biofuge Fresco) (4°C, 2 min) after being grown at
37°C for 12 h in 10 ml TSB with aerobic shaking at 100 rpm (C24 Incubator shaker).
The supernatant was then discarded. All cell pellets of the bifidobacteria mix were
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washed twice with 0.85% NaCl at 4,300×g (Sorvall® RC-5B PLUS Superspeed
Centrifuge) (4°C, 15 min). The cells of E. coli O157:H7 were washed twice with
0.85% NaCl at 1,000×g (Sorvall® Biofuge Fresco) (4°C, 2 min) and then resuspended
in 1 ml 0.85% NaCl. The bifidobacteria mix was suspended in 10 ml 11% NFDM
with the addition of 10 μl E. coli O157:H7 from the 0.85% NaCl suspended solution,
and incubated at 37°C for 24 h with aerobic shaking at 100 rpm (C24 Incubator
shaker). To prepare the control, 10 μl of E. coli O157:H7 from the 0.85% NaCl
suspended solution were incubated in 11% NFDM at 37°C for 24 h with aerobic
shaking at 100 rpm (C24 Incubator shaker). The E. coli O157:H7 counts were
measured during incubation at 0, 4, 8, 24 h, by the spread plate method on TSA (Silk
and Donnelly, 1997).
In further research, the bifidobacteria mix and 10 μl of E. coli O157:H7
were incubated in MRS broth. Method was identical to the one utilized for the
bifidobacteria mix and 10 μl of E. coli O157:H7 incubated in 11% NFDM (described
above). The colony number of E. coli O157:H7 was measured at 0, 4, 8, 24 h during
incubation, by the spread plate method, on TSA. The pH of media was also measured
during incubation.
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Inhibitory Effect of Bifidobacteria on Acid-adapted Escherichia coli O157:H7
One milliliter of E. coli O157:H7 was collected by centrifugation at
1,000×g (Sorvall® Biofuge Fresco) (4°C, 2 min) after being grown at 37°C for 12 h in
10 ml TSB with aerobic shaking at 100 rpm (C24 Incubator shaker). The supernatant
was discarded. The cell pellets of E. coli O157:H7 were washed twice with 0.85%
NaCl at 1,000×g (Sorvall® Biofuge Fresco) (4°C, 2 min) and then suspended in 1 ml
TSB supplemented with 10 g/l glucose. Media were acidified with 1 N hydrochloric
acid (final pH following incubation 4.8±0.007). After incubation at 37°C for 12 h
with aerobic shaking at 100 rpm (C24 Incubator shaker), the cells of acid-adapted E.
coli O157:H7 were prepared. (Leenanon and Drake, 2001)
The cultures of nine strains of bifidobacteria were centrifuged together at
4,300×g (Sorvall® RC-5B PLUS Superspeed Centrifuge) (4°C, 15 min) after being
grown separately at 37°C for 14 h in 10 ml MRS broth under anaerobic conditions.
All cell pellets of bifidobacteria mix were washed twice with 0.85% NaCl at 4,300×g
(Sorvall® RC-5B PLUS Superspeed Centrifuge) (4°C, 15 min). The cells of
acid-adapted E.coli O157:H7 were collected by centrifugation at 1,000×g (Sorvall®
Biofuge Fresco) (4°C, 2 min), followed by washing twice with 0.85% NaCl at
1,000×g (Sorvall® Biofuge Fresco) (4°C, 2 min). Cells were then resuspended in 1 ml
0.85% NaCl. The bifidobacteria mix was suspended in 10 ml 11% NFDM with the
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addition of 10 μl of acid-adapted E. coli O157:H7 from the 0.85% NaCl suspended
solution, followed by incubation at 37°C for 24 h with aerobic shaking at 100 rpm
(C24 Incubator shaker). Ten microliters of acid-adapted E. coli O157:H7 from 0.85%
NaCl were incubated in 11% NFDM at 37°C for 24 h with aerobic shaking at 100
rpm (C24 Incubator shaker) was the control. The colony number of acid-adapted E.
coli O157:H7 was measured at 0, 4 (log phase), 8 (stationary phase) and 24 h during
incubation, by the spread plate method on TSA.

Effect of Supernatant of Bifidobacteria on Escherichia coli O157:H7
The cultures of nine strains of bifidobacteria were centrifuged together at
4,300×g (Sorvall® RC-5B PLUS Superspeed Centrifuge) (4°C, 15 min) after each
species was grown separately at 37°C for 14 h in 10 ml MRS broth under anaerobic
conditions. All cell pellets of bifidobacteria mix were washed twice with 0.85% NaCl
at 4,300×g (Sorvall® RC-5B PLUS Superspeed Centrifuge) (4°C, 15 min). The
bifidobacteria mix was suspended in fresh MRS broth, followed by incubation at
37°C with aerobic shaking at 100 rpm (C24 Incubator shaker) for 8 h. The mixture
was centrifuged at 30,000×g (Sorvall® RC-5B PLUS Superspeed Centrifuge) (4°C, 20
min). The supernatant was collected and divided into two parts. The pH of one part
was adjusted to 6.50 (pH of fresh MRS broth) with 6 N NaOH (Yamamoto et al.,
2003).
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To prepare the E. coli O157:H7 culture, 1 ml of E. coli O157:H7 were
centrifuged at 1,000×g (Sorvall® Biofuge Fresco) (4°C, 2 min) after being grown at
37°C for 12 h in 10 ml TSB with aerobic shaking at 100 rpm (C24 Incubator shaker).
The culture was washed twice with 0.85% NaCl by centrifugation at 1,000×g
(Sorvall® Biofuge Fresco) (4°C, 2 min).
Ten microliters of the E. coli O157:H7 cells were suspended into the two
previous parts of the bifidobacteria supernatant that were prepared previously, and
then incubated at 37°C with aerobic shaking at 100 rpm (C24 Incubator shaker) for 24
h. The E. coli O157:H7 counts were measured during incubation at 0, 4, 8 and 24 h by
the spread plate method on TSA. The pH value of the bifidobacteria supernatant was
also measured at each sampling period.

Statistical Analysis
Mean values and standard deviations (SD) were calculated from data
obtained from three replications in each experiment. A randomized complete block
design was utilized to examine differences (P≤0.05) among treatments, and a
completely randomized design was utilized to examine differences (P≤0.05) among
treatments for each incubation time, in each experiment. Fisher’s protected least
significance difference (LSD) test was then used to separate treatment means (P≤0.05)
(SAS version 9.0; SAS, 2004) when significant differences occurred.

CHAPTER IV
RESULTS AND DISCUSSION
Reddish-violet color (Appendix Table 2) formation indicating the presence
of Fructose-6-phosphoketolase (F6PPK) and observation of purple, rod-shaped
colonies observed under the microscope after Gram-staining confirmed that the
cultures and stocks produced and stored at -80°C were bifidobacteria.
The growth curves for the nine strains of bifidobacteria selected (Figures
4.1 and 4.2) (incubated in MRS broth at 37°C in anaerobic conditions) showed that
full-growth was attained after 14h. The growth of E. coli O157:H7 (ATCC 43890),
shown in Figure 4.3, (incubated in TSB at 37°C with aerobic shaking at 100 rpm)
demonstrated that full-growth was attained after 12 h. This figure also indicated that
the log and stationary phases of E. coli O157:H7 occur at 4 and 8 h, respectively.
Acid-adapted E. coli O157:H7 (ATCC 43890) (Figure 4.4) (incubated in TSB at 37°C
with aerobic shaking at 100 rpm) attained full-growth after 12 h. This growth curve
also revealed that the log and stationary phases occur as 4 and 8 h, respectively.
Accordingly, 4 h and 8 h were chosen as the times to take samples for the survival of
acid-adjusted and unadjusted E. coli O157:H7 in the experiments.
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Figure 4.1

Growth curve (absorbance, OD600 value) of bifidobacteria in MRS
broth for 16 h of incubation at 37°C under anaerobic conditions (n=3)

37
6.60
6.40
6.20

pH value

6.00
Bifidobacterium spp. VSB1

5.80

B.bifidum 791
5.60
Bifidobacterium lactis/animalis Bb12
5.40

B. longum 15708

5.20
5.00
0

2

4

6

8

10

12

14

16

10

12

14

16

Incubation time (h)

7.00

6.50

pH value

6.00

B. longum VMKB S2B

5.50

B.bifidum 15696
B.bifidum VMKB 221
B.longum VMKB 211

5.00

B.bifidum VMKB 213

4.50
0

2

4

6

8
Incubation time (h)

Figure 4.2

pH value of bifidobacteria in MRS broth for 16 h of incubation at 37°C
under anaerobic conditions (n=3)
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Figure 4.3

Growth curve of E. coli O157:H7 (ATCC 43890) and media pH in TSB
for 24 h of incubation at 37°C with aerobic shaking at 100 rpm (n=3)
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Figure 4.4

Growth curve of acid-adapted E. coli O157:H7 (ATCC 43890) and
media pH in TSB supplemented with 10g/l glucose (final pH following
incubation: 4.8±0.007) and incubated at 37°C for 24 hours with aerobic
shaking at 100 rpm (n=3)
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Preliminary Experiment: Effect of Low pH
In order to detect pH effect on E. coli O157:H7, 10 μl of E. coli O157:H7
were incubated in acid-adjusted and unadjusted media (11% NFDM and MRS broth)
during 24 h of incubation at 37°C with aerobic shaking at 100 rpm (Figure 4.5).
Initial colony number of E. coli O157:H7 for 10 μl E. coli O157:H7 in acid-adjusted
11% NFDM (pH 3.81 before growth) and MRS broth (pH 3.94 before growth) was
about 6.06 and 6.03 log CFU/ml, respectively (Appendix Table 7). For unadjusted
11% NFDM (pH 6.39 before growth) and MRS broth (pH 6.46 before growth), initial
colony number of E. coli O157:H7 was the same (P>0.05), about 6.0 log CFU/ml.
The E. coli O157:H7 counts increased over time (P≤0.05) and reached around 8.87
log CFU/ml after 24 h incubation in unadjusted 11% NFDM. E. coli O157:H7 counts
increased (P≤0.05) by 2.79 log CFU/ml after 8 h incubation MRS broth, and finally
reached 8.81 log CFU/ml after 24 h incubation. As for acid-adjusted media, E. coli
O157:H7 counts decreased (P>0.05) shortly after 8 h incubation in acid-adjusted 11%
NFDM and then decreased (P≤0.05) greatly to around 1.20 log CFU/ml after 24h. On
the other hand, E. coli O157:H7 counts from acid-adapted MRS broth decreased
(P≤0.05) greatly to non-detectable levels between 4 and 24 h. From these data above,
it was concluded that the survival of E. coli O157:H7 was influenced by the pH of the
two media.
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Figure 4.5

Survival of E. coli O157:H7 (ATCC 43890) in acid-adjusted or unadjusted media (11% NFDM and MRS broth)
during 24 h of incubation at 37°C with aerobic shaking at 100 rpm (n=3)
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Escherichia coli O157:H7 is highly acid tolerant. Many researches have
been accomplished on the effect of low pH on E. coli O157:H7. Buchanan and Bagi
(1994) reported that the minimum pH for the growth of E. coli was 4.0-4.5. When the
pH falls below the minimum, the numbers of E. coli O157:H7 will decline. This
experiment confirmed the conclusion. However, E. coli O157:H7 is still able to
survive for a long time (much more than one day) in acid food, like fermented
sausages, apple cider, and apple juice (pH 3.6-4.0). Since several outbreaks
contributed by a low level of E. coli O157:H7 in acid food had been reported (Park et
al. 2001).
The Food and Drug Administration requires that a heating or pasteurization
step must be added for acid food products, and that their pH be maintained at or
below 4.6 by acid or acid ingredients (Doyle, 1991). Therefore, Breidt et al. (2004)
indicated that if only pH is considered, acid-resistant pathogens, like E. coli O157:H7,
might be a potential threat to acidified foods. In order to remove the pathogen
thoroughly, more measures need to be applied. Acidified food products were reported
to be safe for many years without other treatments due to organic acids present in
those products (Breidt et al., 2004). Type of acid and acid concentration influences
the effect of pH on the growth of E. coli O157:H7. Shelef (1994) cited that the
inhibitory effect of organic acids were due to “chelation of iron and inhibition of
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lactate dehydrogenase”. Abdul-Raouf et al. (1993) recorded that acetic > lactic ≥
citric was the sequence of acids which had relative inhibitory effect on E. coli
O157:H7 in beef slurries. Considering those factors above, 1 N hydrochloric acid was
applied in the experiment to reflect the effects of pH alone.

Inhibitory Effect of Bifidobacteria on Escherichia coli O157:H7

Inhibitory Effect of Bifidobacteria on E. coli O157:H7 in 11% NFDM
Survival of E. coli O157:H7 in 11% NFDM combined with nine strains of
full-growth bifidobacteria mix during 24 h of incubation at 37°C with aerobic shaking
at 100 rpm is shown in Figure 4.6 (Appendix Table 8). In the control test, E .coli
O157:H7 counts increased (P≤0.05) around 2.26 log CFU/ml after 8 h of incubation
and reached 8.72 log CFU/ml (from 6.06 log CFU/ml at 0 h) after 24 h in the control.
Escherichia coli O157:H7 counts decreased (P≤0.05) greatly in the bifidobacteria mix
+ 10μl E. coli O157:H7 between 8 h and 24 h to non-detectable numbers. This
suggests that bifidobacteria may have an inhibitory effect on E. coli O157:H7 during
incubation in 11% NFDM at 37°C with aerobic shaking at 100 rpm.
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Figure 4.6

Survival of E. coli O157:H7 (ATCC 43890) in 11% NFDM combined with bifidobacteria mix during 24 h of
incubation at 37°C with aerobic shaking at 100 rpm (n=3)
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Bifidobacteria are regarded as probiotics and thought to provide health
benefits to humans. The injection of bifidobacteria with foods may help to lighten the
symptom of gastrointestinal tract disease, inhibit some pathogens (like Salmonella,
Campylobacteria, Escherichia coli etc.), and enhance the immune system and so on
(Ding et al., 2005). Although scientific data is very limited, bifidobacteria have been
utilized in many kinds of dairy foods. Yogurt is milk fermented by probiotics and is
one of the most popular food delivery systems for bifidobacteria cultures. Ding et al.
(2005) have confirmed that cell-free extracts of milk fermented by 10 probiotic
bacteria (five Bifidobacterium strains and five Lactobacillus strains) inhibited the
growth of Campylobacter jejuni. However, numerous challenges, skills, knowledge
and advanced technology are required during its manufacture. In order to develop
high-quality Bifidus products, not only the taste and other sensory properties are
important, but the viability of bifidobacteria is also critical. A 107 CFU/ml viable
bifidobacteria has been demanded to be the minimum count for fresh dairy products
in Japan (Ishibashi and Shimamura, 1993).
This experiment revealed that although the effect of bifidobacteria under
aerobic conditions toward human health benefits is unknown, the bifidobacteria may
still have an inhibitory effect on E. coli O157:H7, regardless of the viability.
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Inhibitory Effect of Bifidobacteria on E. coli O157:H7 in MRS Broth
One medium suitable for the growth of bifidobacteria is MRS broth. In
order to further study the inhibitory activity of bifidobacteria against E. coli O157:H7,
the medium was changed from 11% NFDM to MRS broth (Figure 4.7). In the
bifidobacteria mix + 10μl E. coli O157:H7, E. coli O157:H7 counts decreased
(P≤0.05) to non-detectable levels after 8 h incubation, Simultaneously, E. coli
O157:H7 counts increased (P≤0.05) about 2.8 log CFU/ml in the control. When
comparing the survival of E. coli O157:H7 in MRS broth combined with
bifidobacteria mix with the one in 11% NFDM (Figure 4.8), the results are quite
similar (P>0.05) (Appendix Table 10). Escherichia coli O157:H7 combined with
bifidobacteria mix in either media reached non-detectable levels after 8 h, while E.
coli O157:H7 counts reached non-detectable levels after 24 h incubation in
acid-adjusted media (Figure 4.9). Those comparisons indicate that bifidobacteria have
an inhibitory effect on E. coli O157:H7 during incubation in 11% NFDM and MRS
broth at 37°C with aerobic shaking at 100 rpm. Also, this shows that these
phenomenon were created not only by the low pH of media.
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Figure 4.7

Survival of E. coli O157:H7 (ATCC 43890) and media pH in MRS
broth combined with bifidobacteria mix during 24 h of incubation at
37°C with aerobic shaking at 100 rpm (n=3)
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Figure 4.8

Survival of E. coli O157:H7 (ATCC 43890) in 11% NFDM or MRS broth combined with bifidobacteria mix
during 24 h of incubation at 37°C with aerobic shaking at 100 rpm (n=3)
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Figure 4.9

Survival of E. coli O157:H7 (ATCC 43890) when combined with bifidobacteria mix in the media (11% NFDM
and MRS broth) and E. coli O157:H7 in acid-adjusted media during 24 h of incubation at 37°C with aerobic
shaking at 100 rpm (n=3)
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Research on the inhibitory effect of bifidobacteria on the E. coli O157:H7
has been conducted in vitro and vivo. The effect of bifidobacteria on the survival of E.
coli O157:H7 in vitro was mainly attributed to several factors: the production of lactic
acid and acetic acid, hydrogen peroxide, bacteriocins and the competition for
nutrients (Leahy et al., 2005). According to Gagnon et al. (2004), 2μl of overnight
bifidobacterial cultures spotted on 1.5% MRS agar plates, overlaid with E. coli
O157:H7 were able to create zones of clear agar around themselves. As for in vivo,
besides the forementioned factors, competition of adhesion receptors (Caco-2 cells),
the creation of anti-toxin materials and improvement of the immune system also
affected E. coli O157:H7 survival (Leathy et al., 2005). Asahara et al. (2004) reported
inhibitory effect of (109 CFU/ml) bifidobacteria on (104 CFU/ml) E. coli O157:H7 in
drinking water. Decreased E. coli O157:H7 counts in our study (Appendix Table 10)
were consistent with other research findings. However, their studies also emphasized
that the inhibitory effect of bifidobacterial cultures depended on the concentration and
viability of bifidobacteria cells. Exposure of bifidobacteria mixture under aerobic
condition in our experiments showed that large amount of bifidobacteria had strong
inhibitory effect on E. coli O157:H7, regardless if the viability.
Since E. coli O157:H7 was non-detectable after 8 h incubation (Figure 4.7),
the amount of substances created by bifidobacteria to inhibit the pathogen must have
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been enough at this incubation time. Thereby, the pH value of the mixture at 8 h is
regarded as a standard to change the pH of those media (11% NFDM and MRS broth)
to evaluate the effect of low pH on E. coli O157:H7 in the preliminary experiment
(Figure 4.5). Eight hours were also chosen as the incubation time for the
bifidobacteria mix under aerobic conditions to prepare their supernatant in order to
estimate the effect of outcome on E. coli O157:H7.

Acid Adaption

Inhibitory Effect of Bifidobacteria on Acid-adapted E. coli O157:H7
Acid adaptation has been reported to prolong the survival time of E. coli
O157:H7 in severe acidic conditions (Cheng et al., 2002). The induction of acid
tolerance also helps organisms to survive other stresses (Rowbury, 1995).
Acid-adapted E. coli O157:H7 (Figure 4.4) achieved full growth in 12 h.
Acid-adapted E. coli O157:H7 counts (Figure 4.10) increased (P≤0.05) around 3.10
log CFU/ml after 24 h incubation in the control, while acid-adapted E. coli O157:H7
counts were non-detectable after 8 h when combined with the bifidobacteria mix. The
results indicate that bifidobacteria also have an inhibitory effect on the acid-adapted E.
coli O157:H7.
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Figure 4.10

Survival of acid-adapted E. coli O157:H7 (ATCC 43890) in 11% NFDM combined with bifidobacteria mix
during 24 h of incubation at 37°C with aerobic shaking at 100 rpm (n=3)
52

Plate count of acid-adapted and unadaped E. coli O157:H7
(log CFU/ml)

10.00
9.00
8.00
7.00
6.00

10μl E.coli O157:H7 combined with
bifidobacteria

5.00

10μl acid-adapted E.coliO157:H7
combined with bifidobacteria

4.00

10μl acid-adapted E.coli O157:H7

3.00
10μl E.coli O157:H7

2.00
1.00
0.00
0

5

10

15

20

25

30

Incubation time (h)

Figure 4.11

Survival of acid-adapted and unadapted E. coli O157:H7 (ATCC 43890) in 11% NFDM combined with
bifidobacteria mix during 24 h of incubation at 37°C with aerobic shaking at 100 rpm (n=3)
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There was no difference (P>0.05) between colony numbers of acid-adapted
and unadapted E. coli O157:H7 in NFDM, when combined with the bifidobacteria
mix (Figure 4.11). Leyer et al., (1995) reported that E. coli O157:H7, pre-adapted to
pH 5, increased in survival rates in acidic foods, such as fermented salami and apple
cider. Some other reports also indicate that acid adaptation prolong the survival of E.
coli in different food systems (Goodson and Rowbury, 1989; Cheng and Chou, 1999).
However, Cheng and Chou (2001) pointed out that acid adaptation reduced the
survival of E. coli O157:H7 in low-fat yoghurt stored at 7°C. Our findings differ from
these researcher since we found was no difference between acid-adapted and
unadapted cell counts for E. coli O157:H7. The difference between our findings and
others may be due to: (1) different storage temperature: the lower the storage
temperature, the more resistant the E. coli O157:H7 towards milk fermented by
bifidobacteria mix; (2) different cultures of bifidobacteria and E. coli O157:H7; (3)
different composition of milk (i.e., different concentration of fat and other
ingredients); and (4) different procedures for preparation of the acid-adapted E. coli
O157:H7: For example, Tsai and Ingham (1997) reported another method to create
(acid-adapted) cells of E. coli O157:H7: E. coli O157:H7 incubationed at 37°C for 18
h in TSB followed by washing and transfering to pH 5.0 (pH adjusted with 6 N HCl)
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and incubated at 37°C for 4 h. The choice of the method, culture and media depends
on the requirement and objective of the experiment.

Supernatant of Bifidobacteria Mix

Survival of E. coli O157:H7 in the supernatant of bifidobacteria mix
Another factor that is considered to be one of the main reasons that
inhibitory effect on E. coli O157:H7are the substances that are created by
bifidobacteria mix under aerobic conditions. After 4 h incubation, E. coli O157:H7
counts decreased (P≤0.05) by 6.06 log CFU/ml and reached undetectable levels
(Figure 4.12). These data reveals that the supernatant without bifidobacteria mix
might contain substances that are lethal to E. coli O157:H7. However, after changing
the pH value of the supernatant to 6.50 (pH of fresh MRS broth), the E. coli O157:H7
counts increased (P≤0.05) by 2.59 log CFU/ml after 24 h incubation at 37°C (Figure
4.12). These results appear similar to the ones in fresh MRS broth (Figure 4.13).
This comparison showed that low pH may be the main factor that contributes to the
inhibitory effect of bifidobacteria on E. coli O157:H7. This agrees with reports by
Asahara et al. (2004), who concluded that the creation of acetic acid (thus low pH)
inhibited the production of Shiga-like toxin. However, in comparison with the change
of colony number of E. coli O157:H7 incubated in acid-adjusted MRS broth (pH 3.94
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before growth) (Figure 4.14), the time to achieve non-detectable levels of E. coli
O157:H7 incubated in the supernatant and death rate was much faster (4 h vs. 24 h),
(P≤0.05) for nonacid-adjusted (≥1.5 log CFU/ml) than for adjusted (≥0.3 log CFU/ml)
E. coli O157:H7. The pH value of supernatant (pH 4.10-4.20) was also higher than
the one of acid-adjusted MRS broth (Appendix Table 16). Therefore, it is possible
that there are antimicrobial substances created by bifidobacteria to accelerate the
death of E. coli O157:H7 and that these substances may lose their antimicrobial
characteristic without acid condition or combined with NaOH (the pH of the
supernatant was adjusted by 6 N NaOH).
Gibson and Wang (1994) indicated that the antagonistic activity of
bifidobacteria toward Gram-negative pathogens was acid due more to the secretion of
large amounts of antimicrobial substances (like several organic acids, hydrogen
peroxide, and bacteriocins as mentioned above) than acid production. Inhibitory
effect of soluble substances in the supernatant of bifidobacteria cultures on E. coli
O157:H7 has been studied both in vivo and vitro. Kim et al. (2001) reported that the
supernatant of B. longum HY8001 might have inhibitory effects by binding to vero
cytotoxins (VTs) that are produced by E. coli O157:H7, thus disturbing the
attachment of VTs to globotriaosylceramide (Gb3). The attachment of VTs to Gb3 in
the gut epithelium is the primary step for E. coli O157:H7 to cause and develop
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disease. Cell-free extracts of milk fermented by bifidobacteria and lactobacilli at 37°C
for 24 h inhibited the growth of Campylobacter jejuni (Ding et al., 2005). These
results are similar to our experiments, confirming the antimicrobial effect of
substances created by bifidobacteria. However, since fermentation is an anaerobic
process and caused by enzymes of living microorganisms, those substances are most
likely different from the ones created under aerobic conditions in our experiments.
As for the ingredients in the substances created by bifidobacteria under
aerobic conditions, there are some possibilities: the F6PPK found in Bifidobacterium
species ferments glucose to produce acetate and lactate (Figure 2.2). The F6PPK
pathway also transfers oxygen to create various compounds such as superoxide and
hydrogen peroxide and cause oxygen toxicity under aerobic conditions (Figure 2.1)
(Tamine et al. 1995). As has been mentioned, acetic and lactic acids have inhibitory
effects on E. coli O157:H7. Hydrogen peroxide was reported to “have a strong
oxidizing effect on bacterial cells, sulphydryl groups of cell proteins and membrane
lipids” (Ouwehand and Vesterlund, 2004). Hydrogen peroxide is also known as a
weak acid and can be neutralized by NaOH just like acetic and lactic acids. In
conclusion, organic acids and hydrogen peroxide might be the main reasons that
caused the death of E. coli O157:H7 in the supernatant isolated from nine strains of
bifidobacteria.
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Figure 4.12

Survival of E. coli O157:H7 (ATCC 43890) and media pH in the
supernatant of bifidobacteria during 24 h of incubation at 37°C with
aerobic shaking at 100 rpm (n=3)
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Figure 4.13

Survival of E. coli O157:H7 (ATCC 43890) in pH adjusted MRS supernatant or fresh MRS broth during 24 h
of incubation at 37°C with aerobic shaking at 100 rpm (n=3)
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Figure 4.14
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Survival of E. coli O157:H7 (ATCC 43890) in MRS supernatant or acid-adjusted (fresh) MRS broth during 24
h of incubation at 37°C with aerobic shaking at 100 rpm (n=3)
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As for other materials produced by bifidobacteria, since only some of them
have been extensively studied, further research in the area is needed. For example,
bacteriocins found in almost every bacterium were close to antibiotics, however, so
far “there is no enough evidence to improve the effect of bacteriocins collected from
gram-positive bacteria on gram-negative bacteria, without the addition of any
membrane-active compound” (Ouwehand and Vesterlund, 2004).

CHAPTER V
SUMMARY AND CONCLUSIONS
The antimicrobial activity of a bifidobacteria mixture against Escherchia
coli O157:H7 under aerobic conditions was systematically evaluated.
The mixture of nine strains of bifidobacteria had a strong inhibitory effect
on E. coli O157:H7 during incubation in 11% NFDM or MRS broth aerobically at
37°C.
Two main factors had been proposed to cause the effect of bifidobacteria on
the survival of E. coli O157:H7: (1) low pH (pH around 3.8); (2) antimicrobial
substances created by bifidobacteria during incubation under aerobic conditions.
Low pH had the ability to destroy E. coli O157:H7 after incubation in
acid-adjusted 11% NFDM and MRS broth at 37°C. There were no differences
between acid-adapted and unadapted E. coli O157:H7 in withstanding bifidobacteria
when incubated in 11% NFDM.
The supernatant collected from bifidobacteria mix after incubation in MRS
broth at 37°C with shaking was lethal to E. coli O157:H7. However, once the pH of
the supernatant was adjusted to 6.5 (from 4.3), E. coli O157:H7 was able to grow.
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This seemed to indicate that low pH was the main reason for the antagonistic effect of
bifidobacteria. However, comparing the results from E. coli O157:H7 incubated in
supernatant with the one incubated in acid-adjusted MRS broth (4 h vs. 24 h), a
different conclusion was reached. The outcome revealed that other materials
contained in the supernatant accelerate the death of E. coli O157:H7 and the material
might be inactivated by NaOH or under low-acid conditions.
Additional research needs to be conducted in order to determine the exact
ingredient in the supernatant that inhibit E. coli O157:H7 to confirm those results.
The effect of cell extracts of bifidobacteria on the pathogen may be another
meaningful subject to investigate. As for further application in industry, cost and
safety must also be considered.
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Table 1

Habitats of the species of the genus Bifidobacterium

Species
B. adolescentis
B. angulatum
B. animalis
B. asteroides
B. bifidum
B. boum
B. breve
B. catenulatum
B. choerinum
B. coryneforme
B. cuniculi
B. denticolens
B. dentium
B. gallicum
B. gallinarum
B. indicum
B. infantis
B. inopinatum
B. lactis
B. longum
B. magnum
B. merycicum
B. minimum

Habitat
Feces of human adult; bovine rumen; wewage; human
vagina
Sewage; feces of human adult
Feces of rat, chicken, rabbit calf, and guinea pig; sewage
Intestine of Apis melligera
Feces of human adult, infant and suckling calf; human
vagina
Bovine ruman; feces of piglet
Feces of infant and suckling calf, human vagina; sewage
Feces of infant and human adult; sewage
Feces of piglet; sewage
Intestine of Apis melligera
Feces of rabbit
Human dental caries
Human dental caries and oral cavity; feces of human
adult; abscess and appendix
Human feces
Chicken cecum
Intestine of Apis cerana and A. dorsata
Feces of infant and suckling calf;
Human dental caries
Fermented milk
Feces of human adult, infant, and suckling calf; human
vagina; sewage
Feces of rabbit
Bovine rumen
Sewage

B. pseudocatenulatum
B. pseudolongum
ssp. pseudolongum
ssp. globosum

Feces of infant and suckling calf; sewage

B.psychraerophilum
B. pullorum

Pig caecum
Feces of chicken

Feces of pig, chicken, bull, calf, rat, and guinea pig
Feces of piglet, suckling calf, rat, rabbit, and lamb;
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Table 1

Habitats of the species of the genus Bifidobacterium (continued)

Species
B. ruminantium
B. saeculare
B. scardovii
B. subtile
B. suis
B. thermacidophilum
B. thermophilum
B. thermacidophilum
spp. porcinum

Habitat
Bovine rumen
Feces of rabbit
Adult feces
Sewage
Feces of piglet
Anaerobic digester
Feces of pig, chicken, and suckling calf; bovine rumen;
sewage
Piglet faeces

Adapted from Biavati et al. (2000) and Leahy et al. (2005)

Table 2

Absorbance (OD435nm) value for the detection of enzyme F6PPK to identify bifidobacteria strains (n=3)
Bifidobacteria strain
B. longum VMKB S2B
B.bifidum 15696
B.bifidum VMKB 221
B.longum VMKB 211
B.bifidum VMKB 213
B. longum 15708
Bifidobacterium spp. VSB1
B.bifidum 791
Bifidobacterium lactis/animalis Bb12

OD435nm value (± SD)
0.384±0.024
0.253±0.024
0.529±0.024
0.335±0.024
0.378±0.012
0.391±0.026
0.405±0.034
0.328±0.032
0.447±0.016
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Table 3

Growth curve (absorbance, OD600 value) of bifidobacteria in MRS broth for 16 h of incubation at 37°C under
anaerobic conditions (n=3)

Bifidobacteria strain
B. longum VMKB S2B
B.bifidum 15696
B.bifidum VMKB 221
B.longum VMKB 211
B.bifidum VMKB 213
B. longum 15708
Bifidobacterium spp. VSB1
B.bifidum 791
Bifidobacterium lactis/animalis
Bb12

0
0.006±0.002
0.008±0.004
0.008±0.003
0.008±0.002
0.011±0.009
0.008±0.002
0.009±0.005
0.007±0.002

3
0.017±0.007
0.017±0.011
0.045±0.002
0.022±0.010
0.019±0.012
0.023±0.011
0.021±0.007
0.021±0.008

Incubation Time (h) (± SD)
6
9
0.093±0.024 0.195±0.038
0.034±0.004 0.085±0.033
0.458±0.136 1.016±0.011
0.089±0.026 0.169±0.014
0.101±0.014 0.209±0.034
0.066±0.024 0.132±0.059
0.210±0.088 0.259±0.016
0.146±0.040 0.264±0.019

12
0.839±0.021
0.276±0.198
1.358±0.136
0.615±0.152
0.797±0.014
0.507±0.126
0.759±0.144
0.926±0.103

15
0.892±0.079
0.713±0.196
1.591±0.062
0.829±0.126
1.060±0.156
0.588±0.049
0.979±0.151
1.074±0.093

0.005±0.002 0.018±0.011 0.075±0.032 0.110±0.031 0.477±0.125 0.703±0.158

81

Table 4

pH value of bifidobacteria in MRS broth for 16 h of incubation at 37°C under anaerobic conditions (n=3)

Bifidobacteria strain
B. longum VMKB S2B
B.bifidum 15696
B.bifidum VMKB 221
B.longum VMKB 211
B.bifidum VMKB 213
B. longum 15708
Bifidobacterium spp. VSB1
B.bifidum 791
Bifidobacterium
lactis/animalis Bb12

0
6.46±0.070
6.45±0.069
6.45±0.072
6.46±0.067
6.42±0.079
6.42±0.061
6.42±0.059
6.44±0.064

3
6.44±0.064
6.43±0.084
6.42±0.087
6.44±0.076
6.40±0.078
6.40±0.070
6.41±0.067
6.41±0.067

6.43±0.067

6.42±0.074

Incubation Time (h) (± SD)
6
9
6.32±0.089
6.11±0.038
6.37±0.052
6.23±0.033
5.96±0.201
5.56±0.011
6.35±0.095
6.16±0.014
6.19±0.181
6.00±0.034
6.27±0.150
6.15±0.059
6.22±0.127
5.99±0.016
6.24±0.104
5.96±0.019
6.30±0.123

6.20±0.031

12
6.06±0.157
6.00±0.150
5.36±0.110
5.93±0.118
5.78±0.110
5.83±0.111
5.76±0.076
5.85±0.159

15
5.54±0.148
5.66±0.025
5.04±0.176
5.45±0.100
5.42±0.150
5.71±0.030
5.24±0.120
5.28±0.090

5.95±0.146

5.79±0.015
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Table 5

Growth curve of Escherichia coli O157:H7 (ATCC 43890) and media pH in TSB for 24 h of incubation at 37°C
with aerobic shaking at 100 rpm (n=3)

Incubation Time (h)

pH value (± SD)

OD600 value (± SD)

0
1
2
3
4
5
6
7
8
9
10
11
12
24

7.30±0.238

0.002±0.002
0.008±0.002
0.051±0.017
0.258±0.023
0.710±0.043
0.779±0.043
0.850±0.040
0.770±0.016
0.845±0.014
0.821±0.025
0.851±0.011
0.776±0.072
0.783±0.054
0.800±0.056

6.44±0.044

5.86±0.091

6.06±0.057
5.98±0.295

Plate count
(log CFU/ml) (± SD)
6.079±0.040
6.676±0.333
7.766±0.599
8.173±0.278
8.990±0.363
9.050±0.416
10.270±1.062
9.204±0.372
9.055±0.190
9.052±0.105
9.166±0.251
8.903±0.037
9.079±0.389
8.930±0.303
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Table 6

Growth curve of acid-adapted E. coli O157:H7 (ATCC 43890) and media pH in TSB supplemented with 10g/l
glucose (final pH following incubation: 4.8±0.007) and incubated at 37°C for 24 hours with aerobic shaking at 100
rpm (n=3)

Incubation Time (h)

pH value (± SD)

OD600 value (± SD)

0
1
2
3
4
5
6
7
8
9
10
11
18
24

4.80±0.010

0.007±0.001
0.013±0.001
0.015±0.001
0.038±0.007
0.148±0.033
0.333±0.001
0.485±0.007
0.563±0.018
0.568±0.015
0.563±0.011
0.554±0.038
0.548±0.035
0.535±0.034
0.529±0.031

5.04±0.053

4.57±0.036

4.47±0.006
4.16±0.025
4.12±0.020

Plate count
(log CFU/ml) (± SD)
5.95±0.118
6.11±0.147
6.60±0.072
7.05±0.205
7.87±0.121
8.37±0.126
8.54±0.085
8.56±0.015
8.66±0.085
8.58±0.130
8.62±0.093
8.75±0.208
8.40±0.068
8.06±0.038
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Table 7

Survival of E. coli O157:H7 (ATCC 43890) in acid-adjusted or unadjusted media (11% NFDM and MRS broth)
during 24 h of incubation at 37°C with aerobic shaking at 100 rpm (n=3)
Unadjusted pH

Incubation time (h)

11% NFDM
(pH 6.39)a
D, a

MRS broth
(pH 6.46)a

Adjusted pH
11% NFDM
(pH 3.81)ab

MRS broth (pH
3.94)b

(log CFU/ml) (± SD)
5.96±0.08C, a
6.06±0.13A, a
7.57±0.04B, a
5.94±0.11A, b
8.75±0.08A, a
5.72±0.09A, b
8.81±0.05A, a
1.20±1.05B, b
0.0041
0.28
0.12
1.00
0.82
11

0
5.97±0.07
6.03±0.05A, a
4
8.03±0.05C, a
5.99±0.10A,b
8
8.52±0.17B, a
5.06±0.16B, c
24
8.87±0.03A, a
0C, c
Error Mean Square (EMS) 1
0.0094
0.0091
1
LSD0.05
0.18
0.18
1
Coeff Var (C.V.)
1.23
2.2
2
3
EMS
0.077
12.99
2
LSD0.05
0.46
3.21 3
C.V.
4.50 2
4.50 3
ABCD
— Means (± standard deviations) with the same letter within each column are not different (P>0.05)
abc
— Means (± standard deviations) with the same letter within each row are not different (P>0.05)
1
— Judge the difference among four incubation time in each treatment
2
— Judge the difference among treatments in each incubation time
3
— Judge the difference among treatments as a whole

85

Table 8

Survival of E. coli O157:H7 (ATCC 43890) in 11% NFDM combined with bifidobacteria mix during 24 h of
incubation at 37°C with aerobic shaking at 100 rpm (n=3)

Bifidobacteria mix +10 μl E.coli O157:H7
10 μl E.coli O157:H7
(log CFU/ml) (± SD)
A
0
5.97±0.05
6.06±0.24C
4
5.77±0.15A
7.63±0.14B
8
0.55±0.95B
8.32±0.09A
24
0B
8.72±0.26A
EMS
0.14
LSD0.05
0.64
C.V.
6.84
ABC
— Means and standard deviations with the same letter within each column are not different (P>0.05)
Incubation time (h)
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Table 9

Survival of E. coli O157:H7 (ATCC 43890) and media pH in MRS broth combined with bifidobacteria mix during
24 h of incubation at 37°C with aerobic shaking at 100 rpm (n=3)
Colony number (log CFU/ml) (± SD)
Bifidobacteria mix +
10μl E.coli O157:H7
10μl E.coli O157:H7
6.07±0.13A
5.99±0.10C

pH value (± SD)
Incubation time (h)
Bifidobacteria mix +
10μl E.coli O157:H7
10μl E.coli O157:H7
0
4.94±0.12
6.55±0.050
1
4.41±0.096
6.54±0.061
2
4.22±0.042
6.53±0.061
3
4.11±0.050
6.52±0.055
B
B
4
4.9±0.31
7.58±0.17
4.05±0.046
6.51±0.070
5
4.02±0.038
6.43±0.069
6
3.99±0.026
6.28±0.091
7
3.95±0.044
6.06±0.12
A
C
5.90±0.12
8
8.80±0.032
0
3.95±0.031
C
A
24
0
8.85±0.16
4.04±0.14
5.02±0.45
EMS
0.027
LSD0.05
0.28
C.V.
3.12
ABC
— Means and standard deviations with the same letter within each column are not different (P>0.05)
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Table 10

Survival of E. coli O157:H7 (ATCC 43890) in 11% NFDM or MRS broth combined with bifidobacteria mix
during 24 h of incubation at 37°C with aerobic shaking at 100 rpm (n=3)

Bifidobacteria mix +
10μl E.coli O157:H7 in 10μl E.coli O157:H7 in
10μl E.coli O157:H7 in
11% NFDMa
MRS brotha
Incubation time (h)
MRS brothb
(log CFU/ml) (± SD)
a
0
5.97±0.05
6.07±0.13a
6.06±0.24a
5.99±0.095a
4
5.77±0.15b
4.89±0.31c
7.63±0.14a
7.58±0.16a
8
0.55±0.95b
0c
8.32±0.09a
8.80±0.032a
24
0b
0b
8.72±0.26a
8.85±0.16a
EMS1
0.081
1
LSD0.05
0.47
1
C.V.
5.37
2
EMS
17.89
2
LSD0.05
3.76
2
C.V.
5.37
abc
— Means and standard deviations with the same letter within each row are not different (P>0.05)
1
— Judge the difference among treatments in each incubation time
2
— Judge the difference among treatments as a whole
Bifidobacteria mix +
10μl E.coli O157:H7 in
11% NFDMb
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Table 11

Incubation
time (h)

Survival of E. coli O157:H7 (ATCC 43890) when combined with bifidobacteria mix in the media (11% NFDM
and MRS broth) and E. coli O157:H7 in acid-adjusted media during 24 h of incubation at 37°C with aerobic
shaking at 100 rpm (n=3)
Bifidobacteria mix + 10μl E.coli O157:H7

10μl E.coli O157:H7 in acid-adjusted media

Acid-adjusted
Acid-adjusted MRS broth
11% NFDM
(log CFU/ml) (± SD)
a
0
5.97±0.05
6.07±0.13a
6.06±0.13a
6.03±0.05a
4
5.77±0.15a
4.89±0.31b
5.94±0.11a
5.99±0.10a
8
0.55±0.95d
0d
5.72±0.09a
5.06±0.16b
24
0b
0b
1.20±1.05a
0b
EMS
0.14
LSD0.05
0.62
C.V.
10.06
abcd
— Means and standard deviations with the same letter within each row are not different (P>0.05)
11% NFDM

MRS broth
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Table 12

Survival of acid-adapted E. coli O157:H7 (ATCC 43890) in 11% NFDM combined with bifidobacteria mix during
24 h of incubation at 37°C with aerobic shaking at 100 rpm (n=3)

Bifidobacteria mix +10 μl acid-adapted
10 μl acid-adapted E.coli O157:H7
E.coli O157:H7
Incubation time (h)
(log CFU/ml) (± SD)
A
0
5.53±0.05
5.52±0.18D
4
5.48±0.02A
7.44±0.07C
8
0B
8.33±0.09B
24
0B
8.62±0.15A
EMS
0.0089
LSD0.05
0.16
C.V.
1.84
ABCD
— Means and standard deviations with the same letter within each column are not different (P>0.05)
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Table 13

Survival of acid-adapted and unadapted E. coli O157:H7 (ATCC 43890) in 11% NFDM combined with
bifidobacteria mix during 24 h of incubation at 37°C with aerobic shaking at 100 rpm (n=3)

Bifidobacteria mix +
10μl acid-adapted
10μl unadapted
Incubation time
E.coli O157:H7a
E.coli O157:H7b
(h)
(log CFU/ml) (± SD)
b
0
5.53±0.05
5.97±0.05 a
5.52±0.18 b
4
5.48±0.02 b
5.77±0.15 b
7.44±0.07 a
8
0c
0.55±0.95 b
8.33±0.09 a
24
0b
0b
8.62±0.15 a
EMS1
0.072
1
LSD0.05
0.45
1
C.V.
5.11
2
EMS
17.96
2
LSD0.05
3.77
2
C.V.
5.11
abc
— Means and standard deviations with the same letter within each row are not different (P>0.05)
1
— Judge the difference among treatments in each incubation time
2
— Judge the difference among treatments as a whole
Bifidobacteria mix +
10μl acid-adapted
E.coli O157:H7b

10μl unadapted
E.coli O157:H7a
6.06±0.24 a
7.63±0.14 a
8.32±0.09 a
8.72±0.26 a
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Table 14

Survival of E. coli O157:H7 (ATCC 43890) and media pH in the supernatant of bifidobacteria during 24 h of
incubation at 37°C with aerobic shaking at 100 rpm (n=3)

Incubation time
(h)

Colony number (log CFU/ml) (± SD)
MRS supernatant
MRS supernatant
(adjusted pH 6.50)
(unadjusted pH 4.38)
D
6.01±0.12
6.06±0.075A

pH value (± SD)
MRS supernatant
MRS supernatant
(adjusted pH 6.50)
(unadjusted pH 4.38)
6.59±0.06
4.20±0.09
6.61±0.11
4.19±0.07
6.68±0.09
4.22±0.08
6.61±0.06
4.20±0.08
6.34±0.08
4.20±0.07
5.08±0.34
4.10±0.08

0
2
4
7.14±0.10C
0B
6
8
8.41±0.13B
0B
0B
24
8.60±0.01A
EMS
0.0058
LSD0.05
0.13
C.V.
1.678
ABC
— Means and standard deviations with the same letter within each column are not different (P>0.05)
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Table 15

Survival of E. coli O157:H7 (ATCC 43890) in pH adjusted MRS supernatant or fresh MRS broth during 24 h of
incubation at 37°C with aerobic shaking at 100 rpm (n=3)

Incubation time (h)
0
4
8
24
EMS1
LSD0.05
C.V. 1

MRS supernatant (adjusted pH 6.50)a
(log CFU/ml) (± SD)
a
6.01±0.12
7.14±0.10b
8.41±0.13b
8.60±0.01b

Fresh MRS brotha
5.993±0.095a
7.580±0.165a
8.803±0.032a
8.847±0.162a

0.018
1

0.23
1.75

2

EMS
4.77
2
LSD0.05
2.18
2
C.V.
1.75
ab
— Means and standard deviations with the same letter within each row are not different (P>0.05)
1
— Judge the difference among treatments in each incubation time
2
— Judge the difference among treatments as a whole

93

Table 16

Survival of E. coli O157:H7 (ATCC 43890) in MRS supernatant or acid-adjusted (fresh) MRS broth during 24 h of
incubation at 37°C with aerobic shaking at 100 rpm (n=3)

MRS supernatant
Acid-adjusted (fresh) MRS broth
Incubation time
pH value of MRS supernatant
(h)
(± SD)
(log CFU/ml) (± SD)
a
0
4.20±0.09
6.06±0.075
6.03±0.05a
2
4.19±0.07
5.99±0.10a
4
4.22±0.08
0b
6
4.20±0.08
5.06±0.16a
8
4.20±0.07
0b
24
4.10±0.08
0a
0a
EMS
0.0051
LSD0.05
0.12
C.V.
2.47
abc
— Means and standard deviations with the same letter within each row are not different (P>0.05)
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